CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED
30th June 2025
SUNSHINE HOLDINGS PLC
GROUP CHIEF EXECUTIVE OFFICER'S MESSAGEDear Shareholders,
I am pleased to report a resilient start to FY26, with Sunshine Holdings PLC delivering strong topline and bottom-line growth during the first quarter ended 30th June 2025 (1QFY26). Supported by improving economic conditions and a pickup in consumer activity, the Group sustained positive momentum across its core sectors, building on the strategic foundations laid in FY25.
The Group recorded consolidated revenue of LKR 15.9 bn in 1QFY26, reflecting an 11.6% year-on-year (YoY) growth and a 12.7% increase over the previous quarter. This performance was driven by robust contributions from Healthcare and Agribusiness, while Consumer segment demonstrated a steady recovery. Healthcare was the highest contributor with 54.2%, followed by Consumer segment at 30.1%, and Agribusiness at 15.7%.
Gross profit increased by 22.3% YoY to LKR 5.1 bn, with the Group's gross profit margin expanding by 277 basis points (bps) to 31.8%. This growth was primarily driven by margin expansion in both agribusiness and consumer segments. Earnings before interest and taxes (EBIT) rose to LKR 2.6 bn, a 27.6% YoY growth, with EBIT margin improving by 208 bps to 16.6%, reflecting the resilience of core operations.
These profitability improvements in Agribusiness and Consumer segments translated into stronger bottom-line performance. Profit after tax (PAT) for the quarter stood at LKR 1.7 bn, reflecting a 20.6% YoY growth and a 34.7% improvement over the preceding quarter, despite a 47.8% increase in income tax expenses stemming from changes in Agribusiness taxation
Financial Snapshot
of 44.5% YoY, benefiting from the business model realignment as well as contributions from new partnerships during the quarter. These partnerships are expected to bring long-term value through increased distribution capabilities, and joint business development initiatives.
Healthguard Pharmacy, the retail arm of the healthcare sector, reported a 17.4% YoY revenue increase, driven by growth in prescription volumes and higher transaction values in both the pharmaceutical and wellness categories.
Lina, the Group's pharmaceutical manufacturing business, reported a 19.6% revenue contraction in 1QFY26. This was primarily due to the timing of government delivery schedules and the execution of new MDI machine validation processes during the quarter, which temporarily impacted business unit performance.
ConsumerThe Consumer sector, comprising both export and domestic businesses, showed encouraging signs of recovery in 1QFY26, recording a 3.7% YoY revenue growth to LKR 4.8 bn. This performance was underpinned by improvements in both the domestic and export markets during the quarter.
Revenue from the Branded Tea and Confectionery (domestic) businesses improved by 4.5% YoY, driven primarily by a strong recovery in the confectionery segment.
In branded tea, volumes and value grew marginally by 1.0% YoY and 1.5% YoY respectively during the quarter. Despite challenging consumer sentiment, our core tea brands, Watawala Thei and Zesta, continued to perform well, demonstrating resilience in the Mass market and premium segment. However,
Ran Kahata experienced a challenging quarter, reflecting
1QFY26 Vs 1QFY25 Vs 4QFY25
Healthcare Consumer Agri
8,619
4,781
2,492
14.0%
3.7%
20.7%
10.4%
9.3%
29.8%
intensified competition in the value-for-money segment.
Other
1 nm nm
The confectionery business delivered robust results in 1QFY26,
Revenue
Gross Profit GP Margin
EBIT
EBIT Margin
Net Finance Cost Income Tax Expense PAT
Healthcare15,893
5,053
31.8%
2,645
16.6%
11
(995)
1,660
11.6%
22.3%
+277 bps
27.6%
+208 bps
-144.0%
47.8%
20.6%
12.7%
28.9%
+398 bps
40.2%
+326 bps
-113.9%
72.9%
34.7%
with both volume and value growth. Successful new product introductions contributed to this momentum, translating into a 19.9% YoY revenue increase for the quarter.
The domestic recovery was further complemented by the export business, which maintained its positive trajectory in 1QFY26. Continued strong demand from key international clients drove volume growth, resulting in a 7.2% YoY increase in export revenue.
Topline growth translated into improved profitability for the segment, with Consumer sector EBIT margins rising to 5.8% in
The Healthcare sector delivered steady revenue growth of 14.0%
YoY in 1QFY26, supported by expansion across the pharmaceutical agency, distribution, and retail pharmacy verticals. However, the sector's overall profitability was impacted by a slowdown in the manufacturing business, against same period last year, reflecting the timing of government delivery schedules. As a result, the Healthcare sector EBIT margin contracted to 14.0% in 1QFY26, compared to 15.1% in the same period last year.
The pharmaceutical agency business recorded robust growth of 26.7% YoY. This was driven by the internal realignment of the business model, as well as continued organic growth across core agency portfolios. The medical devices segment also contributed positively, posting a 17.2% YoY revenue increase, sustained by stable demand in key product categories.
Healthguard Distribution recorded a significant topline increase
1QFY26, compared to 3.7% in the same period last year.
AgribusinessThe Agribusiness sector delivered revenue of LKR 2.5 bn in 1QFY26, marking a significant 20.7% YoY growth. This was primarily driven by stronger performance in the palm oil segment, supported by both higher selling prices and increased sales volumes during the quarter.
Palm oil revenue grew by 27.2% YoY, benefiting from favorable market pricing and higher sales volumes, while the dairy business recorded revenue of LKR 278.5 mn in 1QFY26, a decline of 14.6% YoY, due to reductions in both production volumes and realized selling prices.
Despite the contraction in dairy, overall sector profitability improved significantly. The Agribusiness EBIT margin expanded
Page 01
SUNSHINE HOLDINGS PLC
GROUP CHIEF EXECUTIVE OFFICER'S MESSAGE
to 48.8% in 1QFY26, up from 38.8% in the same period last year. This improvement was driven by topline growth in palm oil and sustained cost efficiencies in palm oil operations.
OutlookHealthcare: The Group will continue to prioritize growth in the healthcare sector through expanded pharmaceutical manufacturing capacity at Lina, strengthening of diagnostic capabilities, and widening of retail and distribution channels. The healthcare sector remains a key driver of future growth, supported by both organic and inorganic initiatives.
Consumer: The Consumer sector has shown early signs of recovery, and the Group remains committed to accelerating this momentum. We will continue to defend and grow market sharethrough innovation in product portfolios, deeper retail channel synergies, and focused brand-building initiatives. Expanding the export footprint remains a key strategic priority, with efforts underway to diversify markets and broaden customer reach.
Agribusiness: In Agribusiness, we expect stable palm oil pricing to continue, alongside improved crop yields through greater focus on land productivity. Cost efficiencies and operational optimization will remain central to driving profitability. The dairy segment is expected to gradually stabilize as herd productivity improves.
Further details of the Group's performance are available on the
company website.
(https://www.sunshineholdings.lk/investor/financial-reports)
Shyam SathasivamGroup Chief Executive Officer 31 July 2025
Colombo
Page 02
SUNSHINE HOLDINGS PLC
CONDENSED STATEMENT OF COMPREHENSIVE INCOME - GROUP
Unaudited Unaudited
Continuing operations Revenue
Cost of sales Gross profit Dividend Income Other income
Selling & distribution expenses Administrative expenses
Period ended
30th June 2025
RS '000
15,893,262
(10,840,225)
5,053,037
-92,004
(1,446,425)
(1,054,023)
Period ended
30th June
2024 Change
RS '000 %
14,239,319 12
(10,107,404) 7
4,131,915 22
38,301
57,765 59
(1,259,240) 15
(895,376) 18
Results from operating activities
Finance income Finance cost Net finance cost
Profit before tax
Income tax expense
Profit for the period
Exchange gain/(Loss) on foreign operation translation
Total other comprehensive income for the period
Total comprehensive income for the period
Profit aflributable to:
Owners of the parent company Non-controlling interest
Other comprehensive income aflributable to:
Owners of the parent company Non-controlling interest
Total comprehensive income for the period
Basic earnings per share
Figures in brackets indicate deductions.
The above figures are not audited n/m- not meaningful
2,644,593
150,430
(139,338)
11,092
2,655,685
(995,471)
1,660,214
12
12
1,660,226
1,007,484
652,730
12
-
1,660,226
0.51
2,073,365
204,744
(229,683)
(24,939)
2,048,426
(672,504)
1,375,922
239
239
1,376,161
935,722
440,200
239
-
1,376,161
0.48
28
(27)
(39)
(144)
30
48
21
(95)
(95)
21
8
48
(95)
-
21
-
Page 03
Page 04
SUNSHINE HOLDINGS PLC CONDENSED STATEMENT OF COMPREHENSIVE INCOME - COMPANY
Unaudited Unaudited
Period ended 30th June 2025 RS '000 | Period ended 30th June 2024 RS '000 | Change % | ||
Revenue Cost of sales | 164,646 (160,354) | 166,811 (152,889) | (1) 5 | |
Gross profit | 4,292 | 13,922 | (69) | |
Dividend income | 1,490,066 | 534,701 | 179 | |
Other income | 24,065 | 16,092 | 50 | |
Administrative expenses | (84,007) | (98,983) | (15) | |
Results from operating activities | 1,434,416 | 465,732 | 208 | |
Finance income | 29,350 | 28,014 | 5 | |
Finance cost | (940) | (1,816) | (48) | |
Net finance cost | 28,410 | 26,198 | 8 | |
Profit before tax | 1,462,826 | 491,930 | 197 | |
Income tax expense | (64,396) | 7,187 | (996) | |
Profit for the period | 1,398,430 | 499,117 | 180 | |
Total comprehensive income for the period | 1,398,430 | 499,117 | 180 | |
Basic earnings per share from continuing operations 0.71
Figures in brackets indicate deductions.
* 2024 Figures have been reclassified according to SLFRS 15 as a result of the business module change. Detailed note has provided in Note no 06.
0.25
SUNSHINE HOLDINGS PLC
STATEMENT OF FINANCIAL POSITION - GROUP
Unaudited AuditedAs at 30th June 2025 RS '000 | As at 31st March 2025 RS '000 | ||
ASSETS | |||
Non current assets | |||
Property, plant and equipment | 7,235,940 | 6,828,565 | |
Intangible assets | 236,162 | 235,132 | |
Leasehold right to bare land | 406,306 | 409,805 | |
Biological assets | 3,285,178 | 3,317,573 | |
Investment property | 570,199 | 570,199 | |
Other investments | 575,017 | 578,045 | |
Deferred tax assets | 363,871 | 374,924 | |
Goodwill on Acquisition | 1,310,733 | 1,310,733 | |
Total non-current assets | 13,983,406 | 13,624,976 | |
Current assets | |||
Biological assets-growing crops on bearer plants | 36,510 | 36,510 | |
Inventories | 13,747,660 | 13,860,452 | |
Other investments | 6,194,724 | 4,489,534 | |
Current tax assets | 141,571 | 143,552 | |
Trade & other receivables | 11,781,241 | 9,796,632 | |
Amounts due from related parties | 348,596 | 326,356 | |
Cash & cash equivalent | 4,517,208 | 5,875,414 | |
Total current assets | 36,767,510 | 34,528,450 | |
Total assets | 50,750,916 | 48,153,426 | |
EQUITY AND LIABILITIES | |||
Equity | |||
Stated capital | 4,240,394 | 4,240,394 | |
Reserves | 92,933 | 92,933 | |
Retained earnings | 15,459,714 | 15,965,699 | |
Equity aflributable to owners of the company | 19,793,041 | 20,299,026 | |
Non-controlling interests | 6,947,426 | 6,748,189 | |
Total equity | 26,740,467 | 27,047,215 | |
Non-current liabilities | |||
Loans and borrowings | 1,749,690 | 1,948,938 | |
Employee benefits | 1,148,277 | 1,221,861 | |
Deferred income and capital grants | 33,584 | 34,173 | |
Deferred tax | 1,627,766 | 1,610,069 | |
Total non-current liabilities | 4,559,317 | 4,815,041 | |
Current liabilities | |||
Trade and other payables | 12,383,937 | 9,209,949 | |
Current tax liabilities | 1,817,868 | 1,410,124 | |
Loans and borrowings | 4,312,520 | 4,921,953 | |
Bank overdraft | 936,807 | 749,144 | |
Total current liabilities | 19,451,132 | 16,291,170 | |
Total equity and liabilities | 50,750,916 | 48,153,426 | |
Net asset value per share (Rs.) | 10.06 | 10.32 | |
The above figures are not audited
It is certified that the Financial Statements have been prepared in compliance with the requirements of the Companies
Act No. 7 of 2007.
Group Chief Financial Officer
The Board of Directors is responsible for the preparation and presentation of these financial statements. Approved and signed for and on behalf of the Board.
Chairman Group Chief Executive Officer
July 31st, 2025
Colombo
Page 05
SUNSHINE HOLDINGS PLC
STATEMENT OF FINANCIAL POSITION - COMPANY
Unaudited | Audited | ||
As at 30th June | As at 31 March | ||
2025 | 2025 | ||
RS '000 | RS '000 | ||
ASSETS | |||
Non-current assets Property, Plant and Equipment Intangible assets | 51,775 8,710 | 61,714 9,796 | |
Investment property | 901,730 | 901,730 | |
Investment in subsidiaries | 7,325,815 | 7,325,815 | |
Other investments | 569,890 | 572,918 | |
Deferred tax assets | - | 14,689 | |
Total non-current assets | 8,857,920 | 8,886,662 | |
Current assets | |||
Inventories Current tax assets | 3,307,861 | 1,890,123 | |
Trade & other receivables | 97,667 | 97,667 | |
Amounts due from related parties | 33,877 | 18,193 | |
Other Short Term Investments | 152,639 | 9,459 | |
Cash & cash equivalent | 134,894 | 288,928 | |
Total current assets | 3,726,938 | 2,304,370 | |
Total assets | 12,584,858 | 11,191,032 | |
EQUITY AND LIABILITIES | |||
Equity Stated capital | 4,240,394 | 4,240,394 | |
Reserves | 286,264 | 286,264 | |
Retained earnings | 6,428,792 | 6,211,099 | |
Equity aflributable to owners of the company | 10,955,450 | 10,737,757 | |
Non-controlling interests | - | - | |
Total equity | 10,955,450 | 10,737,757 | |
Non-current liabilities | |||
Loans and borrowings | |||
Deferred tax liability | 46,655 | - | |
Employee benefits | 141,376 | 229,653 | |
Total non-current liabilities | 188,031 | 229,653 | |
Current liabilities Loans and borrowings | 22,267 | 29,763 | |
Trade and other payables | 1,419,069 | 193,857 | |
Amounts due to related parties | - | 2 | |
Loans and borrowings | 41 | - | |
Total current liabilities | 1,441,337 | 223,622 | |
Total equity and liabilities | 12,584,858 | 11,191,032 | |
Net asset value per share (Rs.) | 5.57 | 5.46 | |
The above figures are not audited
It is certified that the Financial Statements have been prepared in compliance with the requirements of the Companies Act No. 7 of 2007.
Group Chief Financial Officer
The Board of Directors is responsible for the preparation and presentation of these financial statements.
Approved and signed for and on behalf of the Board.
Chairman Group Chief Executive Officer
July 31st, 2025
Colombo
Page 06
SUNSHINE HOLDINGS PLC
FOR THE QUARTER ENDED 30TH JUNE 2025
CONDENSED STATEMENT OF CHANGES IN EQUITY - GROUP
Aflributable to owners of the company
In RS '000 | Stated capital | Reserve on exchange gain or loss | General reserve | Fair value gain or loss reserve on AFS | Retained earnings | Total | Non-controlling interest | Total equity |
Balance as at 31st March 2024 | 4,240,394 | 1,600 | 1,258 | 427,615 | 14,233,958 | 18,904,825 | 3,767,868 | 22,672,693 |
Balance as at 1st April 2024 | 4,240,394 | 1,600 | 1,258 | 427,615 | 14,233,958 | 18,904,825 | 3,767,868 | 22,672,693 |
Total Comprehensive Income for three months Profit for three months Total other comprehensive income for three months | - - | -239 | - - | - - | 935,722 - | 935,722 239 | 440,200 - | 1,375,922 239 |
Total Comprehensive Income for three months | - | 239 | - | - | 935,722 | 935,961 | 440,200 | 1,376,161 |
Dividend paid to owners for 2023/24 WHT payment on dividend distribution | - - - | - - | - - | - - | (983,947) (251,617) | (983,947) (251,617) | (280,254) (49,457) | (1,264,202) (301,074) |
Balance as at 30th June 2024 | 4,240,394 | 1,839 | 1,258 | 427,615 | 13,934,115 | 18,605,222 | 3,878,357 | 22,483,579 |
Total Comprehensive Income for nine months | ||||||||
Profit for nine months | - | - | - | - | 3,303,811 | 3,303,811 | 1,234,393 | 4,538,204 |
Total other comprehensive income for nine months | - | (649) | - | (200,842) | - | (201,491) | (47,530) | (249,021) |
Total comprehensive income for nine months | - | (649) | - | (200,842) | 3,303,811 | 3,102,320 | 1,186,863 | 4,289,182 |
Adjustment for Investment property | - | - | - | (136,288) | - | (136,288) | - | (136,288) |
Share issue to IFC | - | - | - | - | - | - | 3,270,000 | 3,270,000 |
Share issue cost to IFC | - | - | - | - | (60,658) | (60,658) | - | (60,658) |
Share isuued by Lina Manufacturing Pvt Ltd to NCI | - | - | - | - | - | - | 256,827 | 256,827 |
Reversal of Dividend payable | - | - | - | - | 7,680 | 7,680 | - | 7,680 |
Equity adjustment on changes in holding in Lina Manufacturing Pvt Ltd | - | - | - | - | 16,390 | 16,390 | (16,390) | - |
Dividend paid to owners for 2023/24 | - | - | - | - | - | - | (513,457) | (513,457) |
Dividend paid to owners for 2024/25 | - | - | - | - | (737,960) | (737,960) | (1,208,300) | (1,946,260) |
WHT payment on dividend distribution | - | - | - | - | (497,680) | (497,680) | (105,711) | (603,391) |
Balance as at 31st March 2025 | 4,240,394 | 1,190 | 1,258 | 90,485 | 15,965,698 | 20,299,025 | 6,748,190 | 27,047,215 |
Total Comprehensive Income for three months | 1,007,484 12 | 1,007,484 12 | 1,660,214 12 | |||||
Profit for three months Total other comprehensive income for three months | 652,730 | |||||||
Total Comprehensive Income for three months | 1,007,496 | 1,007,496 | 652,730 | 1,660,226 | ||||
Dividend paid to owners for 2024/25 WHT payment on dividend distribution | - - | - - | - - | - - | (1,180,737) (332,744) | (1,180,737) (332,744) | (385,469) (68,024) | (1,566,206) (400,768) |
Balance as at 30th June 2025 | 4,240,394 | 1,190 | 1,258 | 90,485 | 15,459,713 | 19,793,041 | 6,947,427 | 26,740,467 |
The above figures are not audited
Page 07
SUNSHINE HOLDINGS PLC
FOR THE YEAR ENDED 30TH JUNE 2025
STATEMENT OF CHANGES IN EQUITY - COMPANY Stated Fair value gain or loss General RetainedIn RS '000
capital reserve on AFS reserve earnings TotalBalance as at 1 April 2023 | 4,240,394 | 183,012 | 1,258 | 5,689,313 | 10,360,297 |
Total Comprehensive Income for three months Profit for three months Total other comprehensive income for three months | - - | - - | - - | 499,117 - | 499,117 - |
Total Comprehensive Income for three months | - | - | - | 499,117 | 499,117 |
Dividend to owners - 2022/23 | - | - | - | (983,947) | (983,947) |
Balance as at 30th June 2024 | 4,240,394 | 429,332 | 1,258 | 5,204,483 | 9,875,467 |
Total Comprehensive Income for nine months | |||||
Profit for nine months | - | - | - | 1,744,579 | 1,744,579 |
Total other comprehensive income for the year | - | (144,326) | - | - | (144,326) |
Total comprehensive income for nine months | - | (144,326) | - | 1,744,579 | 1,600,253 |
Dividend to owners - 2023/24 | - | - | - | (737,960) | (737,960) |
Balance as at 31st March 2025 | 4,240,394 | 285,006 | 1,258 | 6,211,102 | 10,737,761 |
Total Comprehensive Income for three months | |||||
Profit for three months | 1,398,430 | 1,398,430 | |||
Total other comprehensive income for three months | - | - | |||
Total Comprehensive Income for three months | - | - | - | 1,398,430 | 1,398,430 |
Dividend to owners - 2024/25 | - | - | - | (1,180,737) | (1,180,737) |
Balance as at 30th June 2025 | 4,240,394 | 285,006 | 1,258 | 6,428,795 | 10,955,454 |
The above figures are not audited
Page 08
SUNSHINE HOLDINGS PLC
Unaudited
Unaudited Audited
STATEMENT OF CASH FLOWS - GROUP | Period ended 30th June 2025 RS '000 | Period ended 30th June 2024 RS '000 | Year ended 31st March 2025 RS '000 |
CASH FLOWS FROM OPERATING ACTIVITIES | |||
Profit before income tax | 2,655,685 | 2,048,426 | 8,970,846 |
Adjustments for; | |||
Interest Income | (106,139) | (106,758) | (390,506) |
Profit on Disposal of Property, Plant & Equipment | (74) | (474) | (80,746) |
Interest Expense | 139,292 | 190,159 | 809,228 |
Depreciation of Property, Plant and Equipment | 392,029 | 198,594 | 746,069 |
Amortization of Intangible Assets | 18,483 | 18,560 | 72,565 |
Depreciation of mature planations | 27,254 | 43,648 | 176,423 |
Provision/(Reversal) for Bad and Doubtful Debts | 442,144 | 343,458 | 306,685 |
Provision/ (Reversal) of impairment of inventories | (53,817) | 58,543 | (8,718) |
Amortisation of Deferred Income | (589) | (590) | (2,553) |
Amortization of Lesehold land right | 3,498 | 5,219 | 20,875 |
Fair value gain/loss on investment properties | - | - | (49,464) |
Impairment of Goodwill | - | - | 76,373 |
Fair value gain/loss on investments | (14,634) | 7,294 | (10,818) |
Provision for Gratuity excluding acturial gain/loss | 38,683 | 39,000 | 216,040 |
Effect of exchange rate changes on cash and cash equivalents | 12 | 239 | (136,287) |
Fair value gain/loss on Consumer Biological Assets | - | - | 321,222 |
Fair value adjustment of Lease Liability | 2,022 | - | 6,438 |
Re messurment of lease | (106,976) | - | (584,905) |
Operating profit before working capital changes | 3,436,873 | 2,845,318 | 10,458,767 |
(Increase)/decrease in inventories | 166,610 | (679,871) | (1,788,446) |
(Increase)/decrease in trade and other receivables | (2,426,753) | (4,010,154) | (320,797) |
(Increase)/decrease in amounts due from related parties | (22,240) | (200,301) | (294,607) |
Increase/(decrease) in trade and other payables | 1,993,265 | 5,094,905 | 1,606,444 |
Increase/(decrease) in amounts due to related parties | (3) | 12,999 | - |
Cash generated from/ (used in) operations | 3,147,752 | 3,062,898 | 9,661,362 |
Interest paid | (185,531) | (131,442) | (501,602) |
Income tax paid | (935,669) | (701,413) | (3,373,548) |
Gratuity paid | (112,265) | (17,183) | (140,555) |
1,914,287 | 2,212,860 | 5,645,657 | |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Interest Received | 105,157 | 106,758 | 390,130 |
(Investments)/ Disposal in Other Investments | 139,317 | (11,696) | (491,779) |
(Investments)/ Disposal in Short term Investments | (1,826,842) | (991,886) | (2,011,109) |
(Investments)/ Disposal in gratuity fund | - | 33,000 | 50,000 |
Additions to Bearer plants | (1,123) | (11,329) | (34,077) |
Additions of live stock | (41,808) | (37,982) | (186,813) |
Acquisition of PPE | (823,164) | (299,836) | (1,010,352) |
Acquisition of Intangible Assets | (20,047) | (5,517) | (32,764) |
Proceeds from Disposal of PPE | 23,834 | (6,391) | 177,961 |
Proceeds from sales of livestock | 35,148 | 21,086 | 98,682 |
Proceeeds from shares issued by subsidiary to NCI | - | - | 3,209,342 |
Disposal of investment property | - | - | 94,534 |
Acquisition of Investment property | - | (3,693) | (3,693) |
Net cash generated from / (used in) Investing activities | (2,409,528) | (1,207,488) | 250,063 |
CASH FLOWS FROM FINANCING ACTIVITIES | |||
Receipts of Interest Bearing Borrowings | 2,112,572 | 6,691,506 | 20,009,180 |
Repayments of Interest Bearing Borrowings | (2,701,582) | (7,136,161) | (19,629,452) |
Payment to lease creditor | (54,055) | 53,906 | (139,804) |
Dividend Paid | (407,564) | (1,264,202) | (3,723,918) |
Net cash from / (used in) financing activities | (1,050,629) | (1,654,950) | (3,483,994) |
Net increase/(decrease) in cash and cash equivalents | (1,545,870) | (649,578) | 2,411,727 |
Cash and cash equivalents at the beginning of the period | 5,126,271 | 2,714,270 | 2,714,544 |
Cash and cash equivalents at the end of the period | 3,580,401 | 2,064,692 | 5,126,271 |
Cash and cash equivalents | |||
Cash in hand & bank | 4,517,208 | 3,813,367 | 5,875,414 |
Bank overdraft | (936,807) | (1,748,674) | (749,144) |
3,580,401 | 2,064,692 | 5,126,271 |
Figures in brackets indicate deductions. The above figures are not audited
Page 09
SUNSHINE HOLDINGS PLC
STATEMENT OF CASH FLOWS - COMPANY | Unaudited | Unaudited | Audited |
Period ended 30th June 2025 LKR '000 | Period ended 30th June 2024 RS '000 | Year ended 31st March 2025 LKR '000 | |
CASH FLOWS FROM OPERATING ACTIVITIES | |||
Profit before income tax | 1,462,826 | 491,930 | 2,210,772 |
Adjustments for; | |||
Interest income | (29,351) | (28,014) | (96,212) |
Interest expense | 940 | 1,816 | 4,321 |
Fair Value of Investment property | - | - | (56,072) |
Depreciation of Property, Plant and Equipment | 12,395 | 9,411 | 36,525 |
Provision for gratuity | 3,690 | 9,000 | 49,429 |
Operating profit before working capital changes | 1,450,500 | 484,143 | 2,148,764 |
(Increase)/decrease in trade and other receivables | (15,685) | (80,286) | 53,940 |
(Increase)/Decrease in Inventory | - | - | 296 |
(Increase)/decrease in amounts due from related parties | (143,180) | (110,822) | 16,733 |
Increase/(decrease) in trade and other payables | 44,282 | 1,137,918 | 93,621 |
Increase/(decrease) in amounts due to related parties | (2) | 396 | (280) |
Cash generated from/ (used in) operations | 1,335,915 | 1,431,349 | 2,313,074 |
Interest paid | (940) | (18) | (10,933) |
Income tax paid | - | - | (22,101) |
Employee benefits paid | (92,489) | - | (523) |
Net cash generated from / (used in) operating activities | 1,242,486 | 1,431,331 | 2,279,517 |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Interest received | 627 | 23,934 | 100,473 |
(Investments)/ Disposal of Quoted shares | - | 7,549 | 7,549 |
(Investments)/ Disposal of Unquoted shares | - | (14,634) | (14,634) |
(Investments)/ Disposal in Short term Investments | (1,386,641) | (402,197) | (1,041,510) |
Acquisition of intangible assets | (282) | - | (610) |
Proceed from disposal of property, plant & equipment | - | - | 737 |
Acquisition of property, plant & equipment | (2,456) | (19,422) | (34,706) |
Net cash used in investing activities | (1,388,752) | (404,771) | (982,700) |
CASH FLOWS FROM FINANCING ACTIVITIES | (7,809) - | (6,791) (983,947) | (20,551) (1,721,908) |
Payment of lease liabilities Dividend paid | |||
Net Cash generated from / (used in) Financing Activities | (7,809) | (990,738) | (1,742,458) |
Net increase/(decrease) in cash and cash equivalents | (154,075) | 35,822 | (445,643) |
Cash and cash equivalents at the beginning of the period | 288,928 | 723,291 | 734,571 |
Cash and cash equivalents at the end of the period | 134,853 | 759,113 | 288,928 |
Cash and cash equivalents | |||
Cash in hand & bank | 134,894 | 759,113 | 288,928 |
Bank overdraft | |||
134,853 | 759,113 | 288,928 |
Figures in brackets indicate deductions. The above figures are not audited
Page 10
SUNSHINE HOLDINGS PLC SEGMENTAL ANALYSIS
FOR THE QUARTER ENDED 30TH JUNE 2025
Healthcare Agri Consumer Goods
Other Intragroup Group
Restated Restated Restated
RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000
REVENUE | 2026 8,619,475 | 2025 7,563,477 | 2026 2,491,501 | 2025 2,065,358 | 2026 4,781,461 | 2025 4,609,153 | 2026 1,114,752 | 2025 1,103,844 | 2026 (1,113,927) | 2025 (1,102,513) | 2026 15,893,262 | 2025 14,239,319 |
RESULT | ||||||||||||
Profit from operating activities | 1,210,475 | 1,140,290 | 1,216,202 | 802,259 | 279,378 | 168,526 | 2,297,164 | 1,402,286 | (2,358,626) | (1,439,998) | 2,644,593 | 2,073,363 |
Net finance cost | 15,874 | (40,074) | (6,213) | 25,995 | (37,249) | (32,830) | 32,449 | 21,481 | 6,231 | 491 | 11,092 | (24,938) |
Income tax expense | (461,330) | (387,740) | (383,973) | (246,258) | (85,011) | (44,785) | (65,157) | 6,278 | - | - | (995,471) | (672,504) |
Profit for the year | 765,019 | 712,476 | 826,016 | 581,996 | 157,119 | 90,911 | 2,264,456 | 1,430,046 | (2,352,395) | (1,439,507) | 1,660,214 | 1,375,920 |
Other comprehensive income | - | - | - | - | 12 | 239 | - | - | - | - | 12 | 239 |
Total comprehensive income | 765,019 | 712,476 | 826,016 | 581,996 | 157,131 | 91,150 | 2,264,456 | 1,430,046 | (2,352,395) | (1,439,507) | 1,660,226 | 1,376,160 |
OTHER INFORMATION
Segment assets Equity & reserves Total liabilities
Depreciation Capital expenditure
Healthcare Agri Consumer Goods Other
30-Jun-25 | 31-Mar-25 | 30-Jun-25 | 31-Mar-25 | 30-Jun-25 | 31-Mar-25 | 30-Jun-25 | 31-Mar-25 | 30-Jun-25 | 31-Mar-25 | 30-Jun-25 | 31-Mar-25 |
26,303,773 | 25,004,337 | 9,361,305 | 8,713,149 | 9,645,142 | 9,719,932 | 17,281,143 | 15,956,259 | (11,840,447) | (11,240,250) | 50,750,916 | 48,153,426 |
13,851,060 | 14,086,040 | 3,251,748 | 3,747,238 | 4,773,667 | 4,966,815 | 15,585,992 | 15,437,078 | (10,722,000) | (11,189,959) | 26,740,467 | 27,047,215 |
12,452,713 | 10,918,297 | 6,109,557 | 4,965,911 | 4,871,474 | 4,753,117 | 1,695,152 | 519,182 | (1,118,447) | (50,291) | 24,010,449 | 21,106,211 |
RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 |
2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 |
94,616 | 85,608 | 245,653 | 101,025 | 67,893 | 58,818 | 35,431 | 9,768 | - | - | 443,593 | 255,219 |
84,057 | 101,869 | 434,335 | 279,901 | 16,082 | 35,239 | 24,406 | 72,595 | - | - | 558,880 | 489,604 |
RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000 RS '000
Figures in brackets indicate deductions. The above figures are not audited
Page 11
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
-
Corporate information
Sunshine Holdings PLC (the "Company") is a Company incorporated and domiciled in Sri Lanka. The ordinary shares of the Company are listed on Colombo Stock Exchange of Sri Lanka. The address of the Company's registered office is no. 60, Dharmapala Mawatha, Colombo 03, Sri Lanka. The Group is primarily involved in managing portfolio of investments which includes manufacturing, importing and selling of pharmaceuticals & medical devices, selling and export of branded tea, manufacturing of confectionery, fresh milk, palm oil and related products.
-
Interim condensed financial statements
The Interim Condensed Financial Statements for the period ended 30th June 2025, includes the "Company" referring to Sunshine Holdings PLC as the holding Company and the "Group" comprise the Company and subsidiary companies of Sunshine Consumer Lanka Limited (SCL) and its subsidiaries, Sunshine Healthcare Lanka Limited (SHL) and its subsidiaries, Sunshine Wilmar (Pvt) Ltd (SWPL) and its subsidiaries.
The ultimate parent of the company is Lamurep Investments Limited which holds 55.18% of the issued share capital of the company as at 30th June 2025.
-
Approval of financial statements
The Interim Condensed Financial Statements of the Group and the Company for the period ended 30th June 2025, were authorised for issue by the Board of Directors on 31st July 2025.
-
Basis of preparation
The Interim Condensed Consolidated Financial Statements have been prepared in accordance with the Sri Lanka Accounting Standards with effect from 01 January 2014 (SLFRS/LKAS). There were no changes to the accounting policies and methods of computation since the publication of the Annual Report 2024/25. Further, these Financial Statements have been prepared in compliance with the requirement of the Sri Lanka Accounting Standard - LKAS 34 on "Interim Financial Reporting".
The Interim Condensed Consolidated Financial Statements do not include all the information and disclosures required in the Annual Financial Statements, and should be read in conjunction with the Group's annual Consolidated Financial Statements as at 31 March 2025.
Previous period figures and phrases have been rearranged wherever necessary to conform to the current presentation.
-
Significant Accounting Policies
The accounting policies applied in these interim financial statements are the same as those applied in the Group's consolidated financial statements as at and for the year ended 31 March 2025.
-
Standards Issued but not yet Effective
A number of new standards and amendments to standards are effective for annual periods beginning after 1 April 2025 and early application is permitted; however the Group has not early
adopted any of the forthcoming new or amended standards in preparing these condensed consolidated interim financial statements.
-
Basis of Consolidation
Subsidiaries are those entities controlled by the Group. Control is the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities. In assessing control, the Group takes in to consideration that substantive rights that give the ability to direct the activities of the subsidiaries.
The Financial Statements of the subsidiaries are included in the Consolidated Financial Statements from the date the control effectively commences until the date that control effectively ceases. Non- controlling interest is measured at the proportionate share of the acquiree's identifiable net assets. A change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction.
-
Use of judgements and estimates
In preparing these interim condensed financial statements, management has made judgements and estimates that affected the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. Actual results may differ these estimates.
The significant judgments made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those described in the last annual financial statements.
-
Property, Plant & equipment
Recognition and measurement
Property, plant and equipment is recorded at cost less accumulated depreciation and accumulated impairment losses if any, whilst land is measured at fair value.
De-recognitionThe carrying amount of an item of Property, plant & equipment is de-recognised on disposal; or when no future economic benefits are expected from its use. Gains and losses on de-recognition are recognised in income statement and gains are not classified as revenue. When re-valued assets are sold, any related amount included in the revaluation reserve is transferred to Retained Earnings.
DepreciationDepreciation is recognised in income statement on a straight-line basis over the estimated useful lives of each part of an item of property, plant & equipment.
-
Impairment
The Board of Directors has assessed the potential impairment loss of the property, plant and equipment as at 31 March 2025. Based on the assessment, no impairment provision is required to be made in the financial statements as at the reporting date.
-
Impairment
-
Biological assets
The Group recognise the biological assets when, and only when,
Page 12
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
the Company controls the assets as a result of past events, it is probable that future economic benefits associated with the assets will flow to the entity and fair value or cost of the assets can be measured reliably.
Bearer biological assetsTea, rubber, oil palm, cinnamon ,sundry crops and nurseries are classified as bearer biological assets. The bearer biological assets are measured at cost less accumulated depreciation and accumulated impairment losses, if any, in terms of Sri Lanka Accounting Standard LKAS 16 - Property Plant and Equipment as per the ruling issued by Institute of Chartered Accountants of Sri Lanka.
Consumable biological assetsTimber plantation is classified as consumable biological assets and is measured on initial recognition and at the end of each reporting period at fair value less cost to sell. Costs to sell include all costs that would be necessary to sell the assets, including transportation costs. The fair value of trees younger than five years cannot be reliably estimated and are carried at cost less impairment. The cost includes direct material, direct labour and appropriate proportion of directly attributable overheads. Gains or losses arising on initial recognition of timber plantations at fair values less costs to sell and from the change in fair values less costs of plantations at each reporting date are included in profit or loss for the period in which they arise. All costs incurred in maintaining the assets are included in Profit or Loss for the period in which they arise.
LivestockLivestock is measured at their fair value less estimated point of sale costs. Changes in fair value of livestock are recognised in the income statement.
-
Investment properties
Investment properties are measured initially at cost, including transaction costs. The carrying value of an investment property includes the cost of replacing part of an existing investment property, at the time that cost is incurred if the recognition criteria are met, and excludes the costs of day to- day servicing of the investment property. Subsequent to initial recognition, the investment properties are stated at fair values, which reflect market conditions at the reporting date. Gains or losses arising from changes in fair value are included in the income statement in the year in which they arise. Fair values are evaluated at least every 3 years by an accredited external, independent valuer. Investment properties are derecognised when disposed, or permanently withdrawn from use because no future economic benefits are expected. Any gains or losses on retirement or disposal are recognised in the income statement in the year of retirement or disposal.
5.7 InventoriesInventories other than produce stock and nurseries are stated at the lower of cost or net realisable value, after making due allowances for obsolete and slow moving items. The Group uses weighted average cost formula and actual cost in assigning the cost of inventories. The cost includes expenses in acquiring stocks, production and conversion cost and other costs incurred in bringing them to their existing location and condition.
-
Standards Issued but not yet Effective
-
Revenue
Revenue recognition under SLFRS 15 is based on the nature and timing of satisfaction of performance obligations, including significant payment terms.
SLFRS 15 - Revenue from contracts with customers, establishes a comprehensive framework for determining whether, how much and when revenue is recognised. The Group recognises revenue when a customer obtains control of the goods or services. Judgement is used to determine the timing of transfer of control -at a point in time or over the time.
-
Shared Service Income
Presently the company's primary business activity is providing shared services to the group. Accordingly company has reclassified the revenue stream during FY 2024/25. This change aligns with the Company's evolving business model and provides a clearer and more accurate representation of its business activities.
-
Agri Business
Customers obtain the control of the produce after the customer acknowledgement at the dispatch point. Revenue is recognized point in time, at the time of dispatch after the customer acknowledgement.
-
Consumer Brands
Customers obtain control of the goods sold when the goods are delivered to and have been accepted at their premises. Invoices are generated at that point in time. Revenue is recognized when a customer obtains control of the goods or services. Determining the timing of the transfer of control is at a point in time.
-
Healthcare
Customers obtain control of the goods sold when the goods are delivered to and have been accepted at their premises. Invoices are generated at that point in time. Revenue is recognized when a customer obtains control of the goods or services. Determining the timing of the transfer of control is at a point in time.
-
Sunshine Tea
This includes income of tea export to different countries. Revenue is recognised point in time, at the time of dispatch after the customer acknowledgement.
- Rent income
This includes rental income earned from renting out investment property owned by the Subsidiary. Revenue is recognized over time as the rent income is recognized on a straight line basis over the term of the agreement.
6.1 Disaggregation of Revenue from Contracts with CustomersThe disaggregation of revenue has been provided under
segmental analysis.
-
Shared Service Income
- Investments in subsidiaries
Quoted and unquoted investments in shares held on long term basis by the Company and Group are stated at cost less provision for diminution in value of investments.
Page 13
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
7.1 Change In NCI during FY 2024/25On May 6, 2024, International Finance Corporation (IFC) invested a total of LKR 3,269,999,800 in SHL. In consideration of this investment, SHL issued 1,905,239 ordinary voting shares to IFC on October 3, 2024. Following this transaction, SUN now holds 85.27% of the shareholding in SHL, while IFC holds the remaining 14.73%.
On February 6, 2025, Lina Manufacturing (Pvt) Ltd issued 34,253,355 shares to Sunshine Healthcare Lanka Ltd for Rs. 875 million and 10,051,929 shares to Celegon Lanka (Pvt) Ltd for Rs. 257 million. As a result of this transaction, Sunshine Healthcare Lanka Ltd.'s effective shareholding in LMPL increased from 71.6% to 74%.
-
Investment in a Subsidiary during FY 2024/25
On February 6, 2025, Healthguard Pharmacy Ltd issued 12,500,000 shares Sunshine Healthcare Lanka Ltd for Rs. 400 million. Healthguard Pharmacy Ltd. is a fully owned subsidiary of Sunshine Healthcare Lanka Ltd.
-
Amalgamation of Subsidiary during FY 2024/25
SUN has amalgamated with SPL, a fully owned subsidiary of SUN effective from 01st October 2024. Accordingly, the book value of SPL was amalgamated with SUN and SUN continues as the surviving entity.
On 31st December 2024, SUN has transfered its shareholding in SST, a wholly-owned subsidiary, to SCL, wholly-owned subsidiary of the company. The transaction involves the transfer of 4,716,545 shares in SST, valued at a total consideration of LKR 1,940,000,000. As consideration for the transfer, SCL will issue 31,219,826 new shares amounting to LKR 1,940,000,000 to SUN.
- Amalgamation of Subsidiary during FY 2025/26
With effect from 1 April 2025, Lina Spiro (Private) Limited was amalgamated with its parent company, Lina Manufacturing (Private) Limited, in accordance with the applicable legal provisions. As a result of the amalgamation, the carrying value of Lina Spiro (Private) Limited as at 1 April 2025 was combined with Lina Manufacturing (Private) Limited. The business operations previously carried out by Lina Spiro (Private) Limited now continue under Lina Manufacturing (Private) Limited, which is the surviving entity of the amalgamation.
Page 14
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
Valuation of Financial Assets and Liabilities
Accounting Classification and Fair Values
The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value infomraton for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value. The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy.
GROUP COMPANY
Carrying amount Fair value Carrying amount Fair value
30 June 2025
Classification
(Rs.'000) Level 1 Level 2 Level 3
Total
(Rs.'000)
Level 1
Level 2
Level 3 Total
Financial Assets measured at Fair value | 468,749 -6,194,724 5,127 | - -6,194,724 - | - - - 5,127 | 468,749 - - - | 468,749 -6,194,724 5,127 | 468,749 -3,307,861 - | - -3,307,861 - | - - - - | 468,749 - - - | 468,749 -3,307,861 - | |
Investment in Unquoted Shares Investment in Quoted Shares Investment in Unit Trust Investment Fund | Fair value through OCI Fair value through P&L Fair value through P&L Fair value through P&L | ||||||||||
6,668,600 | 6,194,724 | 5,127 | 468,749 | 6,668,600 | 3,776,610 | 3,307,861 | - | 468,749 | 3,776,610 | ||
Financial Assets not measured at Fair value | |||||||||||
Trade and other receivables ** | Amortized cost | 11,781,241 | - | - | - | 11,781,241 | 33,877 | - | - | - | 33,877 |
Investment in Debentures | Amortized cost | 101,141 | - | - | - | 101,141 | 101,141 | - | - | - | 101,141 |
Short term invetsment | Amortized cost | 235,000 | - | - | - | 235,000 | 235,000 | - | - | - | 235,000 |
Amounts due from related parties ** | Amortized cost | 348,596 | - | - | - | 348,596 | 152,639 | - | - | - | 152,639 |
Cash & cash equivalents ** | Amortized cost | 4,517,208 | - | - | - | 4,517,208 | 134,894 | - | - | - | 134,894 |
16,983,186 | - | - | - | 16,983,186 | 657,550 | - | - | - | 657,550 | ||
Financial Liabilities not measured at Fair value | |||||||||||
Loans and borrowings *** Other financial liabilities Bank overdraft ** Other financial liabilities Trade and other payables ** Other financial liabilities Amounts due to related parties ** Other financial liabilities | 6,062,209 936,807 12,383,937 - | - - - - | - - - - | - - - - | 6,062,209 936,807 12,383,937 - | 22,267 41 1,419,069 - | - - - - | - - - - | - - - - | 22,267 41 1,419,069 - | |
19,382,954 | - | - | - | 19,382,954 | 1,441,377 | - | - | - | 1,441,377 | ||
GROUP COMPANY
Carrying amount
Fair value
Carrying amount
Fair value
31st March 2025
Classification
(Rs.'000)
Level 1 Level 2 Level 3
Total
(Rs.'000)
Level 1 Level 2 Level 3
Total
Financial Assets measured at Fair value Investment in Unquoted Shares Investment in Unit Trust Investment Fund | Fair value through OCI Fair value through P&L Fair value through P&L | 468,749 5,959,724 5,127 | -5,959,724 - | - - 5,127 | 468,749 - - | 468,749 5,959,724 5,127 | 468,749 3,072,861 - | -3,072,861 - | - - - | 468,749 - - | 468,749 3,072,861 - |
6,433,600 | 5,959,724 | 5,127 | 468,749 | 6,433,600 | 3,541,610 | 3,072,861 | - | 468,749 | 3,541,610 | ||
Financial Assets not measured at Fair value | |||||||||||
Trade and other receivables ** | Amortized cost | 11,781,241 | - | - | - | 11,781,241 | 33,877 | - | - | - | 33,877 |
Investment in Debentures | Amortized cost | 104,170 | - | - | - | 104,170 | 104,170 | - | - | - | 104,170 |
Short term invetsment | Amortized cost | 235,000 | - | - | - | 235,000 | 235,000 | - | - | - | 235,000 |
Amounts due from related parties ** | Amortized cost | 348,596 | - | - | - | 348,596 | 152,639 | - | - | - | 152,639 |
Cash & cash equivalents ** | Amortized cost | 4,517,208 | - | - | - | 4,517,208 | 134,894 | - | - | - | 134,894 |
16,986,215 | - | - | - | 16,986,215 | 660,579 | - | - | - | 660,579 | ||
Financial Liabilities not measured at Fair value | |||||||||||
Loans and borrowings *** | Other financial liabilities | 6,062,209 | - | - | - | 6,062,209 | 22,267 | - | - | - - - - | 22,267 |
Bank overdraft ** | Other financial liabilities | 936,807 | - | - | - | 936,807 | 41 | - | - | 41 | |
Trade and other payables ** | Other financial liabilities | 12,383,937 | - | - | - | 12,383,937 | 1,419,069 | - | - | 1,419,069 | |
Amounts due to related parties ** | Other financial liabilities | - | - | - | - | - | - | - | - | - | |
19,382,954 | - | - | - | 19,382,954 | 1,441,377 | - | - | - | 1,441,377 | ||
** Classes of financial instruments that are not carried at fair value and of which carrying amounts are a reasonable approximation of fair value. This includes trade receivables, cash and cash equivalents, trade payable, other payables, amounts due to and due from related parties and bank overdraft. The carrying amounts of these financial assets and liabilities are a reasonable approximation of fair values due to their short term nature.
*** Discounted cash flows: The valuation model considers the present value of expected payments, discounted using a risk-adjusted discount rate.
Page 15
8.2. Measurement of Fair Values
Financial Assets and Liabilities measured or disclosed at Fair Value
The fair value of the financial assets and liabilities is included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale.
The Group measures the fair value using the following fair value hierarchy, which reflects the significance of the inputs used in making the measurement. An analysis of the fair value measurement of financial and non-financial assets and liabilities are provided below:
Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.
When available, the Group measures the fair value of an instrument using active quoted prices or dealer price quotations (assets and long positions are measured at a bid price; liabilities and short positions are measured at an ask price), without any deduction for transaction costs. A market is regarded as active if transactions for asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).
This category includes instruments valued using;
quoted prices in active markets for similar instruments,
quoted prices for identical or similar instruments in markets that are considered to be less active, or
other valuation techniques in which almost all significant inputs are directly or indirectly observable from market data.
Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).
This category includes all instruments for which the valuation technique includes inputs not based on observable data and the unobservable inputs have a significant effect on the instrument's valuation.
8.2.a Valuation techniques and significant unobservable inputs
The following valuation techniques used in measuring Level 2 and Level 3 fair values at 30 June 2025 and 31 March 2025 for financial instruments measured at fair value in the statement of financial position, as well as the significant unobservable inputs used.
Unquoted equity instruments - Discounted cash flows
The valuation model considers the present value of expected net cash flows from those investments discounted using a risk adjusted discount rate. The expected cash flows are derived based on the budgeted cash flow forecasts of those investments determined by considering the sensible probability of the forecast EBITDA.
Interest rate swaps/Cross currency swaps - Swap models
The fair value is calculated as the present value of the estimated future cash flows. Estimates of future floating-rate cash flows are based on quoted swap rates, futures prices and interbank borrowing rates. Estimated cash flows are discounted using a yield curve constructed from similar sources and which reflects the relevant benchmark interbank rate used by market participants for this purpose when pricing interest rate swaps. The fair value estimate is subject to a credit risk adjustment that reflects the credit risk of the Group and of the counterparty; this is calculated based on credit spreads derived from current credit default swap or bond prices.
Those assumptions for assets categorised as Level 3 has been described under respective notes to the financial Statements as at 31 March 2025. During the reporting period ended 30 June 2025 and 31 March 2025, there were no transfers between Level 1 and Level 2 fair value measurements.
Page 16
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
Comparatives
The presentation and classification of the Financial Statements of the previous periods have been amended, where relevant, for better presentation and to be comparable with those of the current period.
Stated capital is represented by shares in issue as given below:
No. of shares as at 30th June 2025 31st March 2025
Ordinary shares 1,967,894,516 1,967,894,516
2024/25 (Final)
RS '000
2024/25 (Interim)
RS '000
2023/24 (Final)
RS '000
1,180,737
186,950
983,947
1,967,895
491,974
491,974
0.60
0.38
0.25
Dividend
Dividend (Rs)
No of ordinary shares
Dividend per share (cash
- After share subdivision)
Commitments & contingencies
There has not been significant change in the nature of the contingent liabilities, which were disclosed in the Annual Report for the year ended 31st March 2025.
Income tax
Tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in Statement of Profit or Loss except to the extent that it relates to a business combination, or items recognized directly in equity or in Other Comprehensive Income.
The Group has determined that interest and penalties relating to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them under LKAS 37 Provisions, Contingent Liabilities and Contingent Assets.
Earnings per share
The earnings per share is computed on the profit attributable to ordinary shareholders after tax and non-controlling interest divided by the weighted average number of ordinary shares during the period. Further there was no dilution of ordinary shares outstanding at any time during the period. Therefore, diluted earnings per share is the same as basic earning per share.
Net Assets per share
Net assets per share has been calculated, for all periods, based on the number of shares issued as at the reporting date.
The interim Financial Statements are not audited.
Page 17
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
SHAREHOLDER INFORMATION Audited Market price per shareHighest price Lowest price Last traded price
Period ended 30th June 2025 Rs.27.00
19.20
25.80
Year ended 31st March 2025 Rs.100.75 *
19.80
21.50
* Figures indicated the results prior to the share subdivision.
TWENTY (20) LARGEST SHAREHOLDERS AS AT Name 30th June 2025 No of Shares % Held1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Lamurep Investments Limited Account No.04 & 01 Akbar Brothers Pvt Ltd A/C No 1
Deepcar Limited
Ceylon Business Development Limited Thread Capital (Private) Limited
Citibank Newyork S/A Norges Bank Account 2 Mr. V.Govindasamy
Mr D.P Pieris
Perera And Sons Bakers Pvt Limited Rubber Investment Trust Ltd A/C No 01 Seylan Bank PLC/ Mohamed Nayazdeen
Mr.Hanif Yusoof & NDB Wealth Management
Ranavav Holdingd (Pvt) Ltd & Ranavav Holdings (Pvt) Ltd Ceylon Guardian Investment Trust PLC A/C # 02 M.Gonalagodaghe Buwaneka Dinuwan Thilakaratne
DFCC Bank PLC A/C/ No 2 & A/C/No 1 Ceylon Investment PLC A/C 02
AFC Umbrella Fund- AFC Asia Frontier Fund Asia Securities (Pvt) Ltd (Trading Account) Amaliya Private Limited
1,085,816,556
196,967,420
185,056,304
43,663,504
35,779,668
31,918,548
24,318,000
24,230,017
20,000,000
14,158,916
11,500,000
10,436,476
10,236,838
9,977,108
9,386,085
8,589,782
6,520,000
5,996,044
5,582,442
4,593,568
55.18%
10.01%
9.40%
2.22%
1.82%
1.62%
1.24%
1.23%
1.02%
0.72%
0.58%
0.53%
0.52%
0.51%
0.48%
0.44%
0.33%
0.30%
0.28%
0.23%
Sub Total Others Total1,744,727,276
223,167,240
1,967,894,516
88.66%
11.34%
100.00%
PUBLIC SHARE HOLDING | Requirement by CSE | As at 30th June 2025 |
Option | 1 | 1 |
Float adjusted market capitalization | Above Rs.10,000,000,000/- | 15,978,614,707 |
The percentage of shares held by the public | no minimum % required | 31.35% |
Number of shareholders representing public holding | 500 | 8,535 |
The number of shares held by the Board of Directors are as follows:
Mr. V. Govindasamy Mr.G.Sathasivam Mr. S.G. Sathasivam
As at 30th June 202524,318,000
36,660
12,216
As at 31st March 20256,079,500
36,660
12,216
Page 18
CORPORATE INFORMATION
Name of Company
Sunshine Holdings PLC
Legal Form
Public Limited Liability Company
(Incorporated in 1973 and listed in the Colombo Stock Exchange)
Company Registration Number
PQ13
Principal Activities
Managing a portfolio of businesses
Registered Office
No. 60, Dharmapala Mawatha, Colombo 03
Directors
Mr. D. A. Cabraal Mr. V. Govindasamy Mr. S.G. Sathasivam Mr. G. Sathasivam Mr. S. Shishoo
Mr. Sudarshan Jain Mr. S. Renganathan
Mr. Tyeabally Akbarally
Mr. Reyaz Mihular Ms. Aruni Goonetilleke
Mr. Aruna Deepthikumara
Secretaries
Corporate Services (Private) Limited No. 216, De Seram Place,
Colombo 10
Tel: 011 4 605 100
Auditors
KPMG
Chartered Accountants
32A, Sri Mohamed Macan Marker Mawatha, Colombo 03
Lawyers
F J & G de Saram (Attorney- at -Law)
No.216, de Saram Place Colombo 10
Nithya Partners Attorneys-at-Law No. 97/A, Galle Road Colombo 03
Bankers
Hatton National Bank PLC National Development Bank PLC MCB Bank Limited
Standard Chartered Bank Ltd. Seylan Bank PLC
Nations Trust Bank PLC Commercial Bank PLC Indian Overseas Bank
Hongkong and Shanghai Banking Corporation Limited DFCC Bank PLC
Indian Bank
Credit Ratings
The Company has been assigned a national long-term rating of 'AA+(lka)'; outlook stable by Fitch Ratings
Lanka Limited
Page 19
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |
